Investigators are responsible for ongoing oversight of clinical trials for adherence to the protocol and compliance with regulatory obligations. This may include monitoring the progress and quality of the trial. In addition, a clinical research site may be audited by the University of Michigan, the clinical trial sponsor or a regulatory agency.
Sponsors may require clinical trials to be managed following the International Conference on Harmonisation Good Clinical Practices (ICH GCPs). In conformance with ICH GCPs, clinical trial monitoring services should be provided by qualified personnel.
Monitoring processes or guidelines should include the following details related to site monitoring and audit visits:
MICHR's Clinical Study Monitoring team is available to support research teams.
MICHR SOPs for Monitoring
Monitoring and Audit Visits.docx
Contact us at MICHR-SPGSupport@umich.edu.